SciBase Overview
- Founded
-
1998
- Status
-
Public
- Employees
-
22
- Stock Symbol
-
SCIB
- Share Price
-
$0.12
- (As of Friday Closing)
SciBase General Information
Description
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments: skin cancer and skin barrier assessment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.
Contact Information
- PO Box 3337
- 103 67 Stockholm
- Sweden
SciBase Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.12 | $0.12 | $0.12 - $0.51 | $14.4M | 120M | 97.7K | -$0.06 |
SciBase Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 9,189 | 21,941 | 32,880 | 28,431 |
| Revenue | 1,802 | 1,763 | 1,366 | 1,033 |
| EBITDA | (4,246) | (3,895) | (4,521) | (3,513) |
| Net Income | (4,254) | (4,256) | (4,865) | (3,795) |
| Total Assets | 10,638 | 4,779 | 9,443 | 7,223 |
| Total Debt | 0 | 779 | 316 | 444 |
SciBase Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SciBase Comparisons
Industry
Financing
Details
000000
SciBase Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 | 00000 |
SciBase Patents
SciBase Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3876835-A1 | Methods and medical devices for analyzing epithelial barrier function | Pending | 05-Nov-2018 | 000000000 | |
| US-20220071554-A1 | Methods and medical devices for analyzing epithelial barrier function | Pending | 05-Nov-2018 | 000000000 | |
| EP-3801243-B1 | Impedance measurement device | Active | 24-May-2018 | 0000000000 | |
| EP-3801243-A1 | Impedance measurement device | Active | 24-May-2018 | 0000000000 | |
| US-20210196144-A1 | Impedance measurement device | Pending | 24-May-2018 | A61B5/0531 | 0 |
SciBase Executive Team (12)
SciBase Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00ö00 0000000000 | SciBase | Board Member | 000 0000 |
| 0000000 0000000 | Self | Board Member | 000 0000 |
| 00000 00000000 | Self | Board Member | 000 0000 |
| 0000 000000 | Self | Chairma, Board Member & Interim Chief Executive Officer | 000 0000 |
SciBase Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
SciBase Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SciBase ESG
Risk Overview
Risk Rating
Updated December, 15, 2022
34.6 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,233
Rank
Percentile
Healthcare
Industry
00 of 586
Rank
Percentile
Medical Devices
Subindustry
00 of 200
Rank
Percentile
